Buda Juice Inc. (AMEX: BUDA) is a Consumer Defensive company (Beverages - Non-Alcoholic) with a market capitalization of $75M. The Maz Rating grades it against the other companies in its sector.
Buda Juice Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $5.99, Buda Juice Inc. trades at 31.0x trailing earnings, 4.6x sales and 3.3x book value, with an EV/EBITDA of 18.0. Over the last twelve months it generated about $16M of revenue and $2M of net income. It runs a gross margin of 39.1%, an operating margin of 16.7% and a net margin of 14.9%. It shows return on equity of 13.8%, return on invested capital of 8.6% and a free cash flow yield of 2.9%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 15.52. Over the past 52 weeks the share price ranged from $5.65 to $12.00, with a beta of -1.30.
Buda Juice Inc. does not currently pay a dividend.
Established in 2013, Buda Juice is a Dallas, Texas-based enterprise specializing in the creation and distribution of organic, cold-pressed beverages. The company's offerings, all USDA-certified organic and crafted from fresh fruits and vegetables, are exclusively bottled in glass. Beyond its core juice lines, Buda Juice provides diverse products including one-to-five-day juice cleanse programs, bulk packs of ginger and turmeric shots, and a selection of citrus-based Buda Zen brand juices. Additionally, their range encompasses organic soups and various plant-based milk alternatives. To ensure optimal quality and freshness, every item is meticulously kept refrigerated from its production through to the point of sale. Buda Juice primarily serves wholesale clients.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Buda Juice Inc. (BUDA) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 20.2% / 30% · Interest income / Revenue 2.67% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 20.2% / 33% · Receivables / Mkt Cap (36m) 2.38% / 49% · Interest income / Revenue 2.67% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 20.2% / 33.33% · Receivables / Mkt Cap (24m) 2.38% / 33.33% · Interest income / Revenue 2.67% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.37% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 78.0% / 33.33% · Receivables / Avg Assets (4Q) 6.53% / 33.33% · Interest income / Revenue 2.67% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 77.1% / 33.33% · (Cash+Recv) / Total Assets 86.2% / 33.33% · Interest income / Revenue 2.67% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Buda Juice Inc. (BUDA) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Buda Juice Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 2.67% of each dividend: Buda Juice Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.